I recommend everyone read the article written by Paul Hart from Canary Capital on June 9, 2022. It was published on Stock Head and titled “ASX Biotechnology shares are deeply discounted”.
You’ll get far more insight from Paul than some random troll on HC. Notice how they all start showing up when the market is a bit tough. Learn to ignore it and listen to the people that actually know what they’re talking about. Anyone who has met Paul will know that he’s a very smart investor and advisor.
IHL Price at posting:
32.5¢ Sentiment: Buy Disclosure: Held